Wednesday , June 26 2019

Oracle’s rising sales a reprieve for investors

Bloomberg Oracle Corp.’s shares climbed after the world’s second-largest software maker returned to sales growth and gave a forecast indicating the momentum may continue. For investors, the results were a reprieve amid the company’s uneven transition to cloud-based computing. Revenue increased 1.1 percent to $11.1 billion in the period ended ...

Read More »

Bristol-Myers agrees to divest Celgene’s drug to close deal

Bloomberg Bristol-Myers Squibb Co. agreed to divest one of Celgene Corp.’s most lucrative drugs in order to close their planned $74 billion merger. Under an agreement with the Federal Trade Commission, Bristol-Myers will sell off the psoriasis pill Otezla to appease antitrust regulators’ concerns, the company said in a statement. ...

Read More »

Khamenei scorns talks after being sanctioned by Trump

Bloomberg Iran’s supreme leader scorned the idea of negotiations to ease his country’s tense standoff with the US in his first comments since being sanctioned by Donald Trump. “If we agree in negotiations to their demands, they will make the nation miserable,” Ayatollah Ali Khamenei said, arguing Washington was attempting ...

Read More »